Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.1994 · 353 citations
2. 2Measurement of global haemostasis in severe haemophilia A following factor VIII infusion2007 · 58 citations
3. 3Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care2008 · 65 citations
4. 4Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008)2010 · 14 citations